FHIR IG analytics83,684 resources
By Version
By Authority
By Realm
Start Prev Rows 43800 - 44000 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1090.json | Syphilis [Congenital] (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1091.json | Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1092.json | Congenital heart disease (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1093.json | Hearing impairment (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1095.json | Microcephaly (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1096.json | Developmental delay (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1099.json | Congenital heart disease (ICD10CM) | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1100.json | Hearing impairment (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1104.json | Developmental delay (ICD10CM) | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1106.json | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.112.json | Tetanus (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1130.json | Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1131.json | Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1138.json | Staphylococcus Aureus (Tests by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1139.json | VISA/VRSA (Tests for Vancomycin Resistance Gene) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1145.json | Resistant Lab Result Value | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1148.json | Tests for Vancomycin Susceptibility [Ord] | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1149.json | Proteinuria (Tests for Total Protein in 24H Urine) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.115.json | Mumps (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1150.json | Thrombocytopenia (Tests for Platelets [#/volume] in Blood) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1156.json | Staphylococcus aureus (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1169.json | Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid) | active | 2023-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.117.json | Mumps (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1180.json | Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative]) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1186.json | Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative]) | active | 2023-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1188.json | Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative]) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1196.json | Anthrax (Tests for Bacillus cereus by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1197.json | Cervical Lymphadenitis (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1207.json | CRE (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1212.json | Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1213.json | NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1214.json | Carbapenemase resistance mechanism (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1215.json | Tests for carbapenemase production | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1216.json | Tests for carbapenemase resistance mechanism | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1217.json | Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem] | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1218.json | Tests for carbapenem susceptibility [Ertapenem] | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1219.json | Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1220.json | NU_Tests for Enterobacteriaceae species by Culture and Identification Method | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1224.json | Therapeutic Response to Medication [Improved] | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1225.json | Altered Mental Status (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1230.json | Eschar (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1231.json | Hypotension (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1233.json | Localized Edema (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1234.json | Localized Edema (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1237.json | Tachycardia (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1238.json | Tachycardia (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1239.json | RCKMS Conditions (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.124.json | Poliomyelitis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1240.json | Maternal Condition Puerperium (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1242.json | Non pestis Yersiniosis Infection (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1244.json | Blastomycosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1246.json | Blastomycosis (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1249.json | Blastomycosis (Tests for Blastomyces species by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1250.json | Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1251.json | Blastomycosis (Tests for Blastomyces species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1252.json | Blastomycosis (Tests for Blastomyces species Antibody) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1253.json | Blastomycosis (Tests for Blastomyces species Antigen) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1265.json | Fatigue (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1269.json | Tuberculosis [Latent Infection] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1274.json | Histoplasmosis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1275.json | Histoplasmosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1281.json | Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1294.json | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1295.json | Seizure [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1298.json | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1299.json | Seizure [Unspecified Cause] (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.130.json | Influenza (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1304.json | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1305.json | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1306.json | Body Temperature (Vital Sign) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1307.json | Respiratory Rate (Vital Sign) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1309.json | RSV (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1310.json | RSV (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1312.json | RSV (Tests for RSV Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1314.json | Wheezing (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1317.json | Bronchiolitis (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1325.json | Tobacco Use and Exposure (Social History) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1330.json | Tobacco Smoking Status [Current] (Social History) (LOINC) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1335.json | Hospitalized [Inpatient] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1336.json | Creutzfeldt Jakob Disease (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1337.json | Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1340.json | Prion Disease (Tests for 14_3_3 Protein) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1341.json | Prion Disease (Tests for Abnormal Prion Protein) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1349.json | Cerebrospinal Fluid (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.135.json | Chronic Hepatitis B Virus Infection (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1350.json | Endocervical (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1351.json | Tissue (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1352.json | Specimen from a Normally Sterile Site (Specimen Type)(SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1353.json | Urethral Swab (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1355.json | Wound (Specimen Type) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1359.json | Hepatitis E (Tests for hepatitis E virus IgM Antibody) | active | 2023-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.136.json | Invasive Pneumococcal Disease (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1360.json | Hepatitis E (Tests for hepatitis E virus Antibody) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1363.json | Epiglottitis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1364.json | Organisms (Tests by Microscopic Observation by Gram Stain) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1369.json | Serum (Specimen Type) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1378.json | Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1379.json | Fish Poisoning (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1388.json | Occupational Asthma (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1389.json | Asthma (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1390.json | Asthma (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1391.json | Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1393.json | WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1400.json | Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative]) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1402.json | Cancer [Malignant Neoplasms] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1403.json | Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1404.json | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1405.json | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1407.json | Cancer [Malignant Neoplasms] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1418.json | Alpha gal syndrome (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1420.json | Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative]) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1422.json | Ptosis of Eyelid [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1423.json | Ptosis of Eyelid [Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1424.json | Constipation [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1426.json | Intubation [Respiratory Tract] (Procedure) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1430.json | Infant Botulism (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1446.json | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1447.json | MRSA (Disorders (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1449.json | Staphylococcus aureus infection (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.145.json | Varicella (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1450.json | Staphylococcus aureus infection (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1452.json | MRSA (Tests by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1453.json | MRSA (Tests for Methicillin Resistance Gene) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1454.json | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1458.json | Tests for Cefoxitin Susceptibility [OrdQn] | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1459.json | Organisms (Tests in Blood by Culture and Identification) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1460.json | Bacteria (Tests in Blood by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1461.json | Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification) | active | 2024-06 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1462.json | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1463.json | VRE (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1464.json | VRE (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1465.json | VRE (Tests by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1466.json | Enterococcus species (Tests by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1468.json | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1469.json | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1470.json | Enterococcus species (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1471.json | Amebiasis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1473.json | Amebiasis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1476.json | Amebiasis (Tests for Entamoeba histolytica Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1482.json | Norovirus (Tests for Norovirus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1485.json | Norovirus (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1487.json | Clostridioides difficile infection (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1491.json | C. diff infection (Tests for C diff Toxin Nucleic Acid) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1492.json | C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1505.json | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1507.json | Arsenic Exposure and Toxicity (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1509.json | Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1513.json | Urine (Specimen Type) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1514.json | Mercury Exposure and Toxicity (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1515.json | Cryptococcosis (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1516.json | Cryptococcosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1520.json | Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1523.json | Cryptococcosis (Tests for Cryptococcus species Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1524.json | Cryptococcosis (Tests for Cryptococcus species Antigen) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1525.json | Mercury Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1528.json | Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1532.json | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1533.json | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1534.json | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1538.json | Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.154.json | Hepatitis C Virus Infection (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1540.json | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1541.json | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1542.json | Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1543.json | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1544.json | Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1545.json | Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1546.json | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1551.json | Meningitis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1552.json | Bacterial Meningitis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1553.json | Fungal Meningitis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1554.json | Parasitic Meningitis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1555.json | Bacterial Meningitis (Disorders) (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1559.json | Photophobia (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1562.json | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1563.json | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1564.json | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1565.json | Viruses [Causing Meningitis] (Tests for Nucleic Acid) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1566.json | Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1567.json | Bacteria [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1574.json | Invasive Group B Streptococcus (Disorders) (ICD10CM)) | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1577.json | Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1578.json | Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method) | active | 2025-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1580.json | Animal Bite [Dog] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1581.json | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1582.json | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1584.json | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1585.json | Animal Bite [Dog] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1586.json | Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1587.json | Animal Bite [Excluding Mammals] (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1588.json | Cadmium Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1604.json | Vaccine Adverse Event (Disorders) (ICD10CM) | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1605.json | Vaccine Adverse Event (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1606.json | Vaccinia disease or adverse event (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.161.json | Vibriosis (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1612.json | Blepharitis [Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1613.json | Keratitis [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1614.json | Keratitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1620.json | Anaphylaxis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.1626.json | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct |